IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR(+)HER2(-) breast cancer via CX3CR1(+) macrophages.

Petroni G, Galassi C, Gouin KH 3rd, Chen HH, Buqué A, Bloy N, Yamazaki T, Sato A, Beltrán-Visiedo M, Campia G, Jiménez-Cortegana C, Shah A, Kirchmair A, Massa C, Wickenhauser C, de Andrea CE, Navarro-Rubio B, Serrano-Mendioroz I, Navarro Manzano E, Satty AM, Rippon B, Finotello F, Trajanoski Z, Zhou XK, Scandura JM, García-Martínez E, Ayala de la Peña F, Rodríguez-Ruiz ME, Seliger B, Sánchez-Margalet V, de la Cruz-Merino L, Basho RK, Shiao SL, McArthur HL, Formenti SC, Knott SRV, Galluzzi L

Open source

DOI
10.1038/s43018-025-01007-z
Published
2025 Oct
Container
Nature cancer
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s43018-025-01007-z,
  title = {IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR(+)HER2(-) breast cancer via CX3CR1(+) macrophages.},
  author = {Petroni G and Galassi C and Gouin KH 3rd and Chen HH and Buqué A and Bloy N and Yamazaki T and Sato A and Beltrán-Visiedo M and Campia G and Jiménez-Cortegana C and Shah A and Kirchmair A and Massa C and Wickenhauser C and de Andrea CE and Navarro-Rubio B and Serrano-Mendioroz I and Navarro Manzano E and Satty AM and Rippon B and Finotello F and Trajanoski Z and Zhou XK and Scandura JM and García-Martínez E and Ayala de la Peña F and Rodríguez-Ruiz ME and Seliger B and Sánchez-Margalet V and de la Cruz-Merino L and Basho RK and Shiao SL and McArthur HL and Formenti SC and Knott SRV and Galluzzi L},
  year = {2025},
  journal = {Nature cancer},
  doi = {10.1038/s43018-025-01007-z},
  url = {https://doi.org/10.1038/s43018-025-01007-z}
}

RIS

TY  - JOUR
TI  - IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR(+)HER2(-) breast cancer via CX3CR1(+) macrophages.
AU  - Petroni G
AU  - Galassi C
AU  - Gouin KH 3rd
AU  - Chen HH
AU  - Buqué A
AU  - Bloy N
AU  - Yamazaki T
AU  - Sato A
AU  - Beltrán-Visiedo M
AU  - Campia G
AU  - Jiménez-Cortegana C
AU  - Shah A
AU  - Kirchmair A
AU  - Massa C
AU  - Wickenhauser C
AU  - de Andrea CE
AU  - Navarro-Rubio B
AU  - Serrano-Mendioroz I
AU  - Navarro Manzano E
AU  - Satty AM
AU  - Rippon B
AU  - Finotello F
AU  - Trajanoski Z
AU  - Zhou XK
AU  - Scandura JM
AU  - García-Martínez E
AU  - Ayala de la Peña F
AU  - Rodríguez-Ruiz ME
AU  - Seliger B
AU  - Sánchez-Margalet V
AU  - de la Cruz-Merino L
AU  - Basho RK
AU  - Shiao SL
AU  - McArthur HL
AU  - Formenti SC
AU  - Knott SRV
AU  - Galluzzi L
PY  - 2025
JO  - Nature cancer
DO  - 10.1038/s43018-025-01007-z
UR  - https://doi.org/10.1038/s43018-025-01007-z
ER  - 

APA

G, P., C, G., 3rd, G. K., HH, C., A, B., N, B., T, Y., A, S., M, B., G, C., C, J., A, S., A, K., C, M., C, W., CE, D. A., B, N., I, S., E, N. M., AM, S., B, R., F, F., Z, T., XK, Z., JM, S., E, G., F, A. D. L. P., ME, R., B, S., V, S., L, D. L. C., RK, B., SL, S., HL, M., SC, F., SRV, K., & L, G. (2025). IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR(+)HER2(-) breast cancer via CX3CR1(+) macrophages.. Nature cancer. https://doi.org/10.1038/s43018-025-01007-z

Source records